Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial.

Udo BavendiekAnika GroßhennigJohannes SchwabDominik BerlinerXiaofei LiuLars MaierThomas GasparAndreas RiethSebastian PhilippRainer HambrechtRalf WestenfeldThomas MünzelSebastian WinklerMartin HülsmannDirk WestermannMarja ZdravkovicRalf LichtinghagenHeiko von der LeyenSilke ZimmermannChristian VeltmannMichael BöhmStefan StörkArmin KochJohann Bauersachs

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)

, or age ≥ 75 years. In any other patient, digitoxin may be safely started at 0.07 mg o.d.

Keyphrases

heart failure
acute heart failure
case report
electronic health record
phase iii
study protocol
phase ii
clinical trial
big data
left ventricular
cardiac resynchronization therapy
atrial fibrillation
open label